HomeFileCoronary disease

Coronary disease

Drug-Coated Balloons (DCB): Sirolimus vs. Paclitaxel in De Novo Lesions in Small Vessels

The use of drug-coated balloons (DCB) offers the advantage of avoiding permanent stent implants, thus reducing the...

Is Coronary Lithotripsy as Effective as Rotational Atherectomy?

Severely calcified lesions currently pose a significant challenge, as they require adequate preparation through non-compliant balloons or...

Optimal Duration of DAPT with Oral Anticoagulation After PCI?: 1 Month vs. 3 Months

While the benefits of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor are recognized, its...

Stentless Strategy in ACS: Perfusion and Drug Coated Balloons

The initial strategy for the treatment of patients at high risk of bleeding (HBR) after percutaneous coronary...

AHA 2023 | MINT: Liberal vs Restrictive Transfusion in Patients with Acute Coronary Syndrome

The aim of this study was to assess hard end points such as death or MI in...

AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction

In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However,...

Low vs High Dose Drug Coated Balloons in Femoropopliteal Territory

The use of drub coated balloons (DCB) in the treatment of femoropopliteal artery disease has grown. Studies...

Coronary Calcification: More Frequent Use of Coronary Lithotripsy as a Recommendation

Coronary calcification, whether concentric or eccentric, has always posed a challenge in percutaneous coronary intervention (PCI) due...